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Tachycardia-Mediated Cardiomyopathy
Secondary to Focal Atrial Tachycardia
Long-Term Outcome After Catheter Ablation
Caroline Medi, BMED,*† Jonathan M. Kalman, MBBS, PHD,* Haris Haqqani, MBBS,*
Jitendra K. Vohra, MD,* Joseph B. Morton, MBBS, PHD,* Paul B. Sparks, MBBS, PHD,*
Peter M. Kistler, MBBS, PHD*‡
Melbourne, Australia
Objectives This study aimed to characterize the incidence, clinical and electrophysiologic features, and long-term outcomes
of patients with tachycardia-mediated cardiomyopathy (TCM) secondary to focal atrial tachycardia (AT).
Background TCM is known to complicate atrial tachyarrhythmias. Little is known of the patient and tachycardia characteristics
associated with the development of left ventricular (LV) dysfunction and the long-term outcomes after cure of tachycardia.
Methods A total of 345 patients with focal AT underwent radiofrequency ablation between January 1997 and July 2008.
A retrospective analysis was performed to identify patients with LV dysfunction, defined as an ejection fraction
50% on echocardiography. Patients with pre-existing structural heart disease (n  14) were excluded. Patients
with TCM (n  30) and without TCM (n  301) were compared. Recovery of LV function was also assessed.
Results The incidence of TCM was 10%. Incessant or very frequent paroxysmal tachycardia was strongly associated with TCM,
compared to patients without TCM (100% vs. 20%, p  0.001). Patients in the TCM group were younger (mean age
39  22 years vs. 51  17 years, p  0.0006) and more frequently male (60% vs. 38%, p  0.001). Patients with
TCM had a longer mean tachycardia cycle length (502  131 ms vs. 402  105 ms, p  0.0001) and slower ventric-
ular rate (117  21 beats/min vs. 141  33 beats/min, p  0.0007) during tachycardia compared with patients
who did not have TCM. Appendage sites are associated with a high incidence of incessant tachycardia (84%) and LV
dysfunction (42%). After successful ablation, LV function was restored in 97% of patients at a mean of 3 months.
Conclusions Cardiomyopathy occurs in 10% of patients with focal AT. A slower incessant tachycardia is more frequently compli-
cated by cardiomyopathy. Long-term restoration of LV function can be achieved after successful catheter ablation of
the tachycardia focus. (J Am Coll Cardiol 2009;53:1791–7) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.014p
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cachycardia-mediated cardiomyopathy (TCM) is an im-
ortant reversible cause of left ventricular (LV) dysfunction
hat may complicate both supraventricular and ventricular
rrhythmias (1,2). Catheter ablation is highly effective in
roviding long-term success for the majority of patients
ith supraventricular arrhythmias (3,4). The mechanistic
nsights into the pathophysiology of TCM are based on
nimal models in which rapid right atrial and ventricular
rom the *Department of Cardiology, Royal Melbourne Hospital, and the Depart-
ent of Medicine, University of Melbourne, Melbourne, Australia; †Department of
ardiology, The Alfred Hospital, Melbourne, Australia; and the ‡Baker Heart
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cholarship from the National Heart Foundation, and a Cardiovascular Lipid
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esearch Scholarship from the National Health and Medical Research Council. Dr.
istler has received research support from the Cardiac Society of Australasia.q
Manuscript received September 15, 2008; revised manuscript received January 26,
009, accepted February 13, 2009.acing has been used to induce heart failure. Prior animal
tudies have demonstrated a relationship between an in-
reasing tachycardia rate and duration and increased severity
f LV dysfunction (5). Although TCM is known to occur
econdary to incessant supraventricular arrhythmias, there is
paucity of data describing the characteristics of focal atrial
achycardia that lead to TCM.
The aim of the present study was to determine the
ncidence of TCM among patients presenting with focal
trial tachycardia (AT), the electrophysiologic characteris-
ics of focal AT associated with the development of revers-
ble LV dysfunction, and the long-term clinical outcome
fter successful catheter ablation.
ethods
tudy population. The study population consisted of a
onsecutive series of 345 patients undergoing radiofre-
uency ablation (RFA) for focal AT between January 1997
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Focal Atrial Tachycardia-Mediated Cardiomyopathy May 12, 2009:1791–7and July 2008. All patients had
clinically documented paroxys-
mal or incessant AT. Compari-
son of P-wave morphology with
the sinus rhythm P-wave was
made to identify ectopic AT.
The lower atrial rate was 100
beats/min with a change or dis-
tinct difference in the P-wave
morphology to the typical sinus
P-wave important in the diagno-
sis of focal AT. Tachycardia was
defined by the presence of 10
consecutive tachycardia beats on
12-lead electrocardiogram or
Holter monitor. Incessant tachy-
ardia was defined as continuous tachycardia or continuous
aroxysms of tachycardia separated by 2 sinus beats (6).
atients had failed therapy with a mean of 1.5  1.2
ntiarrhythmic drugs before the procedure. Patients rou-
inely undergo echocardiography before electrophysiology
EP) study and RFA. Left ventricular dysfunction was
efined as a left ventricular ejection fraction (LVEF) of
50%. Patients were considered to have pre-existing LV
ysfunction when cardiomyopathy occurred in the context
f known significant coronary artery disease, valvular heart
isease, congenital heart disease, or inherited cardiomyop-
thy; cardiomyopathy had been documented before the
nset of tachycardia; or the echocardiographic abnormalities
ere segmental or of a pattern attributable to another cause.
hese patients (n  14) were excluded from the analysis.
omparisons were made between patients with TCM
n  30) and without TCM (n  301).
Of the patients with TCM, 27 of 30 (90%) were in
achycardia at the time of baseline (pre-ablation) echocar-
iogram, and 3 of 30 (10%) were in sinus rhythm. At the
ime of echocardiography, the mean heart rate in the
ncessant population was 114  16 beats/min versus 69  9
eats/min in the sinus rhythm population (p  0.0001).
P study. All patients underwent EP study in the fasting
tate with minimal use of sedation, and after the provision
f informed written consent. All antiarrhythmic drugs were
iscontinued a minimum of 5 half-lives before the
rocedure.
ATHETER POSITIONING. Catheter positioning and the ap-
roach used in our laboratory for ablation of focal AT have
een previously described in detail (7). In brief, catheters
ere positioned in the following manner: 1) coronary sinus
atheter (10-pole) positioned with the proximal bipole at
he ostium of the coronary sinus; 2) crista terminalis
atheter (20-pole) positioned along the crista terminalis;
) His bundle electrogram catheter; and 4) mapping and
blation catheter. When necessary, the 3-dimensional elec-
Abbreviations
and Acronyms
AT  atrial tachycardia
AV  atrioventricular
EP  electrophysiology
LV  left ventricular
LVEF  left ventricular
ejection fraction
RFA  radiofrequency
ablation
TCL  tachycardia cycle
length
TCM  tachycardia-
mediated cardiomyopathyroanatomic mapping system was used. 3APPING AND DEFINITION OF FOCAL AT. Diagnosis of focal
T was made using standard electrophysiologic criteria (7).
natomic localization of the atrial focus was performed
uring tachycardia or atrial ectopy by analysis of the
ollowing: 1) surface electrogram P-wave morphology (8);
) right atrial endocardial activation sequence during tachy-
ardia (9,10); 3) conventional point by point mapping; and
) when necessary, the 3-dimensional electroanatomic map-
ing system. Definitions of anatomic locations of tachycar-
ia origin within the atria have been previously described
6,9–11). In the right atrium, these foci tend to occur along
he crista terminalis (12), tricuspid annulus (13), ostium of
he coronary sinus, and the perinodal region. In the left
trium, foci occur predominantly at the pulmonary vein
stia and less commonly at the mitral annulus, left atrial
ppendage, and left-sided septum.
Tachycardia cycle length was assessed by calculating the
ean cycle length of 10 consecutive tachycardia beats from
ntracardiac electrograms recorded at the time of EP/RFA,
nd is a measure of the atrial rate in tachycardia. The
achycardia cycle length (TCL) is expressed in milliseconds.
entricular rate was assessed by calculating the mean heart
ate of 10 consecutive QRS complexes in tachycardia
ecorded during EP/RFA. Ventricular rate is expressed as
eats/min. Patients with incessant tachycardia had a tachy-
ardia pattern described in the preceding text. One patient
ad incessant atrial ectopy with persistent atrial bigeminy or
rigeminy and was included in this group.
FA. RFA was performed with continuous temperature
eedback control of power output to achieve a target
emperature of 50° to 60°C for a maximum power of 40 to
0 W. The power was reduced to 30 W for tachycardia sites
t the pulmonary vein ostia and within the atrial append-
ges. Irrigated ablation was used where adequate power
ould not be achieved. Acute procedural success was defined
y the absence of tachycardia or ectopy 30 min after ablation
espite infusion of isoproterenol (6 g/min) and burst
trial pacing.
ollow-up. Patients were followed up by the treating
lectrophysiologist and by telephone interview. Any patient
ith symptoms suggestive of recurrent tachycardia was
eviewed by the treating electrophysiologist, and attempts
ere made to document the rhythm. The patients with
mpaired LV function underwent repeat echocardiography
fter successful ablation.
tatistical analysis. All continuous variables are expressed
s mean  SD. Comparisons between groups were per-
ormed with an unpaired Student t test or Mann-Whitney
test. Categorical variables, expressed as numbers and
ercentages, were compared with a chi-square test. A value
f p  0.05 was considered statistically significant.
esults
atient characteristics. The study population included
45 patients (40% male; mean age 50 18 years, range 9 to
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May 12, 2009:1791–7 Focal Atrial Tachycardia-Mediated Cardiomyopathy5 years). Left ventricular dysfunction was present in 44
atients. Fourteen of 44 patients had prior structural heart
isease secondary to ischemic (n  10), congenital (n  2),
ilated cardiomyopathy (n  1), and valvular heart disease
n  1). These patients were excluded owing to alternate
otential mechanisms of impaired LV function. Therefore,
0 of 331 (10%) patients demonstrated cardiomyopathy
econdary to focal AT. Of the patients considered to have
CM, the mean LVEF was 35  11%. Echocardiographic
ssessment of LV function was undertaken during tachy-
ardia in 27 of 30 patients. Of the 30 patients with TCM,
2 underwent echocardiography within 48 h after the
blation procedure. Eleven of 12 patients were in tachycar-
ia during the pre-ablation echocardiogram, and all post-
blation echocardiograms were performed in sinus rhythm.
he mean heart rate during the pre-ablation echocardiogram
or these 12 patients was 110  19 beats/min. There was no
ignificant difference between LVEF pre-ablation versus the
mmediate post-ablation echocardiogram (LVEF 36 10%
s. 39  10%, p  0.5). The clinical characteristics of the
atient population with TCM are presented in Table 1.
achycardia characteristics. Comparisons between pa-
ients with and without TCM are presented in Table 2. The
CM group was younger (mean age of 39  22 years,
ange 9 to 81 years, vs. 51  17 years, range 15 to 85 years;
 0.0006) and was significantly more likely to be male
60% vs. 38%, p  0.001) (Table 2). There was no significant
ifference in symptom duration or use of antiarrhythmic
rugs between the 2 groups.
linical and Tachycardia Characteristics in Patients With Tachycar
Table 1 Clinical and Tachycardia Characteristics in Patients W
Anatomic Site Age (yrs) Male
Symptom
Duration (y
PV (n  8) 36 24 63 (5) 7 8
AA (n  8) 24 7 88 (7) 3 5
Perinodal (n  2) 61 28 100 (2) 0.8 0.4
CS (n  1) 67 0 100 (1) 5 0
CT (n  3) 41 4 0 (0) 5 5
TA (n  3) 44 22 33 (1) 10 13
Multifocal (n  5) 49 28 40 (2) 7 9
alues are mean  SD or % (n). *Premature atrial complex 37% total beats. †Mean rate Holter m
AA atrial appendage; CS coronary sinus; CT crista terminalis; LVEF left ventricular ejection
linical Characteristicsf Patients With and Without TCM
Table 2 Clinical Characteristicsof Patients With and Without TCM
TCM (n  30) No TCM (n  301) p Value
Age, yrs 39 22 51 17 0.0006
Male 60 38 0.001
Incessant/very frequent
paroxysmal
100 20 0.001
Antiarrhythmic drugs 1.4 1.3 1.5 1.1 0.7
Symptom duration, yrs 6 7 6 8 0.9
TCL, ms 502 131 402 105 0.0001
HR, beats/min 117 21 141 33 0.0007
Pre-ablation LVEF, % 35 11 59 1 0.0001r
alues are % or mean  SD.
HR  heart rate; TCM  tachycardia-mediated cardiomyopathy; other abbreviations as in Table 1.There were significant differences in the TCL of the
ctopic AT, and also of the ventricular rate during tachy-
ardia, between patients with and without TCM. Patients
ith TCM had a longer mean atrial TCL and slower
entricular rate during tachycardia than did patients without
CM (TCL 502  131 ms vs. 402  105 ms, p  0.0001;
nd ventricular rate 117  21 beats/min vs. 141  33
eats/min, p  0.0007) (Table 2).
Incessant or frequent paroxysmal tachycardia was signif-
cantly associated with TCM compared with patients who
ad normal LV function (100% vs. 20%, p  0.001).
ncessant tachycardia was present in 27 of 30 patients with
CM: very frequent paroxysmal tachycardia separated by
hort episodes (2 beats) of sinus rhythm was present in 2
atients, and 1 patient had LV dysfunction (EF 36%) after
5-year history of incessant atrial ectopy with normal
entricular function. This unusual presentation followed
ersistent atrial bigeminy/trigeminy on electrocardiography
nd Holter monitoring, although sustained tachycardia was
ot present. After the development of cardiomyopathy,
atheter ablation was performed at the ostium of the
oronary sinus. After successful ablation of the ectopic foci,
here was complete recovery of LV function in this patient
ith frequent isolated ectopy.
Sixteen of the 30 foci that resulted in TCM originated
rom either the atrial appendages (n  8) or the pulmonary
eins (n  8). This reflected the frequent occurrence of
ncessant tachycardias from these anatomic sites.
ncessant AT. Overall, incessant AT occurred in 82 of 331
25%) patients (Table 3). The TCM occurred in 30 of 82
37%) patients with incessant tachycardia. A comparison of
he characteristics of patients with incessant AT who had
CM with those of patients who also had incessant AT but
id not have TCM showed the following: 1) incessant AT
atients with TCM were similar in age (mean age 39  22
ears) and sex (60% male) to incessant AT patients without
CM (mean age 45  18 years, p  0.2; 54% male, p 
.8); 2) symptom duration was not significantly different
etween incessant AT patients with TCM (6 7 years) and
ithout TCM (4  6 years, p  0.5); and 3) in incessant
T patients with TCM, the TCL was longer (502  131
s) and ventricular response rate was slower (mean heart
ediated Cardiomyopathy
achycardia-Mediated Cardiomyopathy
TCL Ventricular Rate
Pre-Ablation
LVEF
407 121 125 14 34 11
616 137 103 19 34 10
502 45 123 11 38 11
N/A* 89† 36
413 54 145 23 40 9
406 115 151 49 45 0
522 32 116 6 34 13
; N/A not applicable; PV pulmonary vein; TA tricuspid annulus; TCL tachycardia cycle length.dia-M
ith T
rs)ate 117  21 beats/min) than in patients who did not have
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Focal Atrial Tachycardia-Mediated Cardiomyopathy May 12, 2009:1791–7CM (TCL 446  106 ms, p  0.05; and heart rate 132 
3 beats/min, p  0.05).
The incidence of incessant AT and incidence of TCM as
er anatomic site of origin is presented in Table 3. Common
natomic sites of incessant tachycardia were the atrial
ppendages (n  16 of 19; 84%) and pulmonary vein ostia
n  26 of 44; 59%) (Fig. 1). These sites also had a high
ncidence of associated TCM (Table 3). Cardiomyopathy
eveloped in 8 of 19 (42%) patients with tachycardia
riginating from the right or left atrial appendages, and in 8
f 44 (18%) patients with a pulmonary vein origin, signifi-
antly higher than from other anatomic locations (14 of 238;
%; p  0.008).
FA. Catheter ablation was attempted in 303 of 345
atients. Ablation was not attempted in the remaining 42
wing to insufficient activity (n 22), close proximity to the
Figure 1 Tachycardia P Waves With Sinus Rhythm in 2 Patient
(Left) This patient was a 53-year-old man who presented with a 6-month history of
the P-wave is broad, inverted, and notched in leads V1 and V2 and positive in lead
atrial appendage (RAA), and radiofrequency ablation was successful in terminating
sant tachycardia. The P-wave in tachycardia is bifid positive in the inferior leads, b
cessfully ablated at the origin of the left atrial appendage (LAA). SR  sinus rhyth
natomic Sites of Origin of Focal Atrial Tachycardia for Entire Stud
Table 3 Anatomic Sites of Origin of Focal Atrial Tachycardia fo
PV (n  44) MA (n  13) AA (n  19) Per
Male 50 (22) 8 (1) 79 (15)
Age, yrs 38 16 53 16 33 18
Incessant 59 (26) 0 (0) 84 (16)
Tachycardia-mediated
cardiomyopathy
18 (8) 0 (0) 42 (8)
alues are % (n) or mean  SD.
MA  mitral annulus; other abbreviations as in Table 1.trioventricular (AV) node (n  12), and multiple changing
orphologies (n  8). Acute success in patients for whom
F was pursued was achieved in 272 of 303 (90%) patients.
n patients with TCM, success without use of medication
as achieved in 26 of 30 (87%) patients at mean follow-up
f 23  21 months. Of the other 4 patients, 2 with right
trial appendage tachycardia had recurrence of post-ablation
achycardia and are now successfully controlled with drugs
ith normalization of LV function; 1 patient had incessant
ultifocal tachycardia unable to be mapped and eliminated
ith RFA, and this patient has been only partially con-
rolled with medication; and 1 83-year-old patient had
ubsequent pacemaker implantation and AV node ablation.
ecovery of LV function. Left ventricular function re-
urned to normal in 29 of 30 (97%) patients at 2.8  2
onths after successful ablation (Fig. 2). One now 20-year-
h Incessant AT
ations. Left ventricular ejection fraction was normal. In atrial tachycardia (AT),
, and avF. Electrophysiology study revealed an origin at the base of the right
chycardia. (Right) This patient was a 32-year-old asymptomatic woman in inces-
nd positive in leads V1 through V6, and negative in lead I. Tachycardia was suc-
ulation
ire Study Population
(n  40) CS (n  27) CT (n  85) TA (n  53) Multi (n  28)
18) 59 (16) 18 (15) 47 (25) 36 (10)
14 40 22 56 13 48 20 57 14
8) 11 (3) 6 (5) 32 (17) 25 (7)
2) 4 (1) 4 (3) 6 (3) 18 (5)s Wit
palpit
s II, III
the ta
road a
m.y Pop
r Ent
inodal
45 (
50
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May 12, 2009:1791–7 Focal Atrial Tachycardia-Mediated Cardiomyopathyld male who presented with incessant tachycardia soon
fter birth has persistent LV dysfunction. Previous attempts
t RFA were unsuccessful owing to multiple changing foci
f tachycardia. Partial control of tachycardia with medical
herapy has led to an improvement in LV function, from
evere (LVEF 22%) to mildly impaired (LVEF 40% to
9%). There have been no instances of syncope or sudden
ardiac death in the TCM group at a mean follow-up of 20
8 months.
iscussion
his study provides a detailed description of cardiomyopa-
hy secondary to focal atrial tachycardia in a large patient
ohort with long-term follow-up. The important findings
ere as follows: 1) 30 of 82 (37%) patients with incessant
achycardia presented with a TCM (30 of 331 patients,
epresenting 10% of the atrial tachycardia cohort); 2) ana-
omic sites with a predilection for incessant tachycardia (the
trial appendages and pulmonary veins) were most fre-
uently complicated by LV dysfunction; and 3) successful
atheter ablation was achieved in 26 of 30 patients. Suc-
essful control with drugs was achieved in 3 of the 4
emaining patients; an 83-year-old patient with an incessant
arahisian tachycardia proceeded to pacemaker implanta-
ion and AV node ablation. Therefore, complete recovery of
V function was obtained in 29 of 30 (97%) patients. There
ere no late adverse events in long-term follow-up.
nimal studies of TCM. In tachypacing-induced animal
odels of heart failure, an increasing rate, longer duration,
nd type of tachycardia are primarily responsible for the
evelopment of myopathic change (14). Constant or inces-
ant rapid pacing at a pre-defined fixed rate is generally used
or the induction of the cardiomyopathic state. In contrast,
achyarrhythmias in humans, even when incessant, demon-
trate significant variability related to diurnal variation and
Figure 2 LVEF Before and After Ablation in Patients With TCM
A total of 27 of 30 patients with tachycardia-mediated cardiomyopathy (TCM)
were in tachycardia during the initial echocardiographic assessment of left
ventricular function. Pre-ablation left ventricular ejection fraction (LVEF) was
35  11%, improving to 59  3% at 2.8  2 months post-ablation.autonomic tone. This is an important consideration when
ridging the gap from “bench to bedside” in interpreting the
ndings from animal models (2). Notwithstanding these
imitations, important insights into the pathophysiology of
CM have been determined.
uman studies of TCM. Tachycardia has been well
escribed as an important cause of reversible LV dysfunc-
ion (15–17). The incidence of TCM is poorly defined and
ikely underestimated. In patients with unexplained cardio-
yopathy, approximately 50% (18,19) have been classified
s idiopathic. Kasper et al. (18) reported that, of 673
onsecutive patients with presumed dilated cardiomyopathy,
case was attributed to tachycardia (18). That is likely to be
n underestimate, particularly among patients with atrial
brillation and dilated cardiomyopathy in whom uncon-
rolled tachycardia may cause or exacerbate heart failure
20). In addition, children with permanent junctional recip-
ocating tachycardia appear vulnerable to the development
f LV dysfunction, with 24 of 85 (28%) children affected in
series (21). TCM has also rarely been reported to
omplicate other frequent paroxysmal or persistent su-
raventricular tachycardias, including AV nodal re-entry
achycardia and AV re-entrant tachycardias (1,16,22). The
iagnosis of AT may be challenging, particularly at ventric-
lar rates of 110 beats/min as presented in the current study.
ifferentiating sinus tachycardia from AT may be difficult,
ith tachycardia considered an “appropriate” compensatory
esponse to LV dysfunction. In the majority of instances, an
nalysis of P-wave morphology will readily rule out a sinus
echanism. However, foci arising from the crista terminalis
r from right-sided pulmonary veins may have a P-wave
orphology indistinguishable from a sinus P-wave and lead
o an incorrect diagnosis of compensatory sinus tachycardia (8).
In the present study, cardiomyopathy developed in one-
hird of patients with incessant AT. When compared with
ll patients with AT who did not have a cardiomyopathy,
atients with TCM demonstrated a longer atrial TCL and
entricular response. Patients with rapid paroxysmal AT
ay be more likely to be symptomatic with palpitations and
ore aware of tachycardia episodes. More rapid tachycardia
s likely to be appropriately diagnosed and not mistaken for
inus tachycardia. Patients with rapid AT may, therefore, be
ecognized earlier and given more rapid treatment, leaving
ess time for TCM to develop. By contrast, patients with
lower incessant tachycardia may not present early with
alpitations, but rather, later with symptoms of cardiac failure.
When a comparison was made between patients with
ncessant tachycardia in whom cardiomyopathy did or did
ot develop, similar differences in cycle length and ventric-
lar response were observed. Symptom duration (although
otoriously difficult to assess), age at presentation, and sex
ere not significantly different. Alternate factors beyond
achycardia rate (and possibly duration) are likely important
n the predisposition to LV dysfunction.
In the present study, foci arising from the atrial append-
ges and pulmonary veins were frequently incessant; how-
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Focal Atrial Tachycardia-Mediated Cardiomyopathy May 12, 2009:1791–7ver, there was no significant difference in the likelihood of
CM developing according to site of origin if tachycardia
as incessant. This observation suggests that the predilec-
ion for TCM to develop relates to the incessant nature of
he focus rather than to the anatomical site of origin.
enetic factors influencing predisposition for TCM to
evelop may play an important role. Angiotensin-converting
nzyme gene polymorphisms have been associated with
CM (23). A genotype containing a deletion allele is
ssociated with elevated angiotensin-converting enzyme and
ngiotensin II concentrations (24). Deshmukh et al. (23)
escribed an increase in the deletion/deletion genotype in
ncessant tachycardia patients with cardiomyopathy com-
ared with normal LV function. This overexpression of the
enin-angiotensin system may account for an individual
redisposition to develop cardiomyopathy in the context of
ncessant tachycardia in some patients.
A high burden of ventricular ectopic activity has been
hown to result in LV dysfunction (25). In the present
tudy, 1 patient had impaired ventricular function in re-
ponse to frequent or “incessant” atrial ectopy. This is a
ighly unusual and rare case of frequent atrial ectopics
esulting in cardiomyopathy, and this patient does not
eflect the clinical outcomes of patients who have a high
urden of atrial or ventricular ectopy seen on Holter
onitoring.
linical implications. In our study population, incessant
achycardia occurred in approximately 25% of patients with
ocal AT, and TCM developed in approximately one-third
f these patients. These tachycardia foci predominantly
riginated from the atrial appendages and from the pulmo-
ary vein ostia. Successful RFA of atrial tachycardia foci was
ossible for the vast majority of these patients and resulted
n complete reversibility of tachycardia-induced LV dys-
unction. At a mean follow-up of almost 2 years, there were
o late sudden deaths among this population.
Recovery of LV function after control of persistent
achycardia has been demonstrated for a range of different
achycardia mechanisms (15–17,26). However, recent data
ave suggested that there may be persistence of structural
bnormalities even with return to normal ventricular func-
ion. Nerheim et al. (27) reported the long-term outcomes
f 24 patients with complete recovery from TCM after
ontrol of differing cardiac arrhythmias. Five patients who
ad recurrence of atrial fibrillation had a very rapid recur-
ence of heart failure, suggesting that some structural LV
bnormalities may have persisted. Three other patients, all
f whom had recurrence of atrial fibrillation (1 had under-
one AV node ablation), died suddenly months to several
ears later despite apparent preservation of LV function,
gain raising the possibility of persistent LV structural
bnormalities (27). We cannot rule out the presence of
ersistent occult LV abnormalities in our population. How-
ver, our data suggest that, for patients undergoing curative
blation of focal AT, late arrhythmia recurrence is rare and
he long-term prognosis is excellent.tudy limitations. The calculation of LV systolic function
n the presence of a shortened diastolic filling time may
esult in an underestimate of LVEF. In this clinical study,
e were unable to control for the effects of differences in
eart rhythm in the assessment of LV function at baseline
nd after successful catheter ablation. In 27 of 30 (90%)
atients, the echocardiography determination of baseline
V function was performed during tachycardia. We have
ncluded the findings from 12 patients in incessant AT who
nderwent an early repeat echocardiogram within 48 h after
he restoration of sinus rhythm by catheter ablation. There
as no significant difference between pre-ablation LVEF
36  10%) and immediate post-ablation LVEF (39 
0%; p  0.5).
onclusions
CM occurred in 10% of patients with focal AT. Incessant
achycardia is necessary for the development of TCM, and
as seen in approximately one-third of the total population
f patients with focal AT. Incessant tachycardias character-
stically originated from the atrial appendages and pulmo-
ary veins and had a significantly longer cycle length than
id paroxysmal tachycardias, which did not result in cardio-
yopathy. Long-term restoration of LV function can be
chieved with successful control or elimination of tachycar-
ia in the majority of patients.
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